Clinical trial
Mechanisms of Action of Dimethyl Fumarate in Relapsing MS
NCT02675413 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mechanisms of Action of Dimethyl Fumarate in Relapsing MS
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- April 30, 2016
- Completion date
- April 30, 2016
- Enrollment
- 0 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.